• Return to Headlines

Shares of PDL BioPharma Rank the Lowest in Terms of P/E Ratio in the Biotechnology Industry (PDLI, GILD, UTHR, BIIB, AMGN)

By David Diaz

Below are the three companies in the Biotechnology industry with the lowest price to earnings (P/E) ratios. P/E is an important valuation tool when comparing companies in the same industry. A higher P/E ratio means that investors are paying more for each unit of net income, so the stock is more expensive compared to one with a lower P/E ratio.

PDL BioPharma ranks lowest with a a P/E ratio of 1.81. Following is Gilead Sciences with a a P/E ratio of 6.09. United Therapeutics ranks third lowest with a a P/E ratio of 7.96.

Biogen Idec follows with a a P/E ratio of 13.36, and Amgen rounds out the bottom five with a a P/E ratio of 14.82.

SmarTrend recommended that its subscribers protect gains by selling shares of United Therapeutics on February 23rd, 2017 by issuing a Downtrend alert when the shares were trading at $145.27. Since that call, shares of United Therapeutics have fallen 16.8%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: lowest p/e ratio pdl biopharma Gilead Sciences United Therapeutics Biogen Idec Amgen

Ticker(s): PDLI GILD UTHR BIIB AMGN